OHYA, S.; MATSUI, M.; KAJIKURI, J. Ca 2+ -Activated K + Channel K Ca 3.1 as a Double-Edged Sword in the Treatment of Inflammatory Bowel Disease. Journal of Gastrointestinal and Liver Diseases, [S. l.], v. 29, n. 4, p. 487–489, 2020. DOI: 10.15403/jgld-3234. Disponível em: https://jgld.ro/jgld/index.php/jgld/article/view/3234. Acesso em: 9 oct. 2026.